pancreatic cancer
New Erasmus MC Subsidiary Develops Personalized Immunotherapy
Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.